학술논문
Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: A 4-year follow-up of a randomised controlled trial
Document Type
Article
Author
Gianni, L.; Dafni, U.; Gelber, R.D.; Azambuja, E.; Muehlbauer, S.; Goldhirsch, A.; Untch, M.; Smith, I.; Baselga, J.; Jackisch, C.; Cameron, D.; Mano, M.; Pedrini, J.L.; Veronesi, A.; Mendiola, C.; Pluzanska, A.; Semiglazov, V.; Vrdoljak, E.; Eckart, M.J.; Shen, Z.; Skiadopoulos, G.; Procter, M.; Pritchard, K.I.; Piccart-Gebhart, M.J.; Bell, R.
Source
In: The Lancet Oncology . (The Lancet Oncology, March 2011, 12(3):236-244)
Subject
Language
English
ISSN
14702045